{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:28:03Z","timestamp":1791379683509,"version":"4.3.3"},"reference-count":0,"publisher":"MedWorks Media","issue":"4S1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacol Bull"],"abstract":"<jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Peripheral inflammatory biomarkers are potential predictors of antidepressant response in major depressive disorder (MDD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study updated a 2022 meta-analysis by extending the literature through January 2026 to clarify these biomarker-response associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed was searched from February 2021 to January 2026. Eligible studies evaluated baseline peripheral biomarkers in adults with MDD before starting \u2a7e4 weeks of pharmacotherapy, comparing responders vs. non-responders. Standardized mean differences (SMD; Hedges\u2019 g) were pooled using random-effects models. Subgroup analyses and meta-regressions examined antidepressant class and publication period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-four studies (16 from the prior review, 8 new) were quantitatively analyzed. In primary pooled analyses, no baseline biomarkers (including CRP and IL-8) significantly differentiated responders from non-responders. However, exploratory analyses revealed a nominal interaction by publication period for IL-2 (p = 0.0112). In recent studies (2021\u20132026), baseline IL-2 was nominally lower in responders than non-responders (SMD = \u22120.81; 95% CI \u22121.59 to \u22120.03; p = 0.04). Similarly, in recent studies restricted to Selective Serotonin Reuptake Inhibitors (SSRIs) or Serotonin\u2013norepinephrine reuptake inhibitors (SNRIs), baseline IL-6 was nominally lower among responders (SMD = \u22120.37; 95% CI \u22120.69 to \u22120.05; p = 0.02). Leave-one-out analyses confirmed overall robustness, though IL-6 showed moderate sensitivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While individual baseline biomarkers have limited utility as standalone predictors when pooling all historical data, lower baseline IL-2 and IL-6 emerge as promising signals for predicting treatment response in contemporary studies (2021\u20132026) and specific antidepressant classes (SSRIs\/SNRIs).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.64719\/pb.20776","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:49:08Z","timestamp":1789807748000},"page":"88-107","source":"Crossref","is-referenced-by-count":0,"title":["Peripheral Inflammatory Biomarkers as Predictors of Antidepressant Treatment Response in Major Depressive Disorder: An Updated Systematic Review and Meta-Analysis"],"prefix":"10.64719","volume":"56","author":[{"given":"Ho Won","family":"Chun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Chul","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54175","published-online":{"date-parts":[[2026,9,17]]},"container-title":["Psychopharmacology Bulletin"],"original-title":[],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:49:10Z","timestamp":1789807750000},"score":1,"resource":{"primary":{"URL":"https:\/\/medworksmedia.com\/pb-article\/peripheral-inflammatory-biomarkers-as-predictors-of-antidepressant-treatment-response-in-major-depressive-disorder-an-updated-systematic-review-and-meta-analysis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":0,"journal-issue":{"issue":"4S1","published-online":{"date-parts":[[2026,9,17]]}},"URL":"https:\/\/doi.org\/10.64719\/pb.20776","relation":{},"ISSN":["2472-2448"],"issn-type":[{"value":"2472-2448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]}}}